MFWM
Motley Fool Wealth Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10M | Buy |
275,082
+125,486
| +84% | +$4.56M | 0.6% | 57 |
|
|
2025
Q1 | $5.42M | Sell |
149,596
-4,239
| -3% | -$153K | 0.32% | 97 |
|
|
2024
Q4 | $6.43M | Sell |
153,835
-14,180
| -8% | -$592K | 0.33% | 91 |
|
|
2024
Q3 | $9.33M | Sell |
168,015
-2,385
| -1% | -$132K | 0.47% | 75 |
|
|
2024
Q2 | $7.01M | Buy |
170,400
+6,324
| +4% | +$260K | 0.36% | 88 |
|
|
2024
Q1 | $7.66M | Sell |
164,076
-159
| -0.1% | -$7.42K | 0.4% | 78 |
|
|
2023
Q4 | $7.86M | Sell |
164,235
-4,024
| -2% | -$193K | 0.41% | 77 |
|
|
2023
Q3 | $6M | Buy |
168,259
+58,139
| +53% | +$2.07M | 0.35% | 86 |
|
|
2023
Q2 | $5.08M | Buy |
110,120
+4
| +0% | +$185 | 0.3% | 89 |
|
|
2023
Q1 | $4.42M | Buy |
110,116
+55,232
| +101% | +$2.21M | 0.28% | 87 |
|
|
2022
Q4 | $2.54M | Sell |
54,884
-1,134
| -2% | -$52.5K | 0.18% | 98 |
|
|
2022
Q3 | $2.32M | Buy |
56,018
+58
| +0.1% | +$2.4K | 0.15% | 106 |
|
|
2022
Q2 | $3.34M | Sell |
55,960
-255
| -0.5% | -$15.2K | 0.21% | 96 |
|
|
2022
Q1 | $4.08M | Buy |
56,215
+71
| +0.1% | +$5.16K | 0.2% | 98 |
|
|
2021
Q4 | $4.72M | Sell |
56,144
-1,948
| -3% | -$164K | 0.21% | 93 |
|
|
2021
Q3 | $5.24M | Sell |
58,092
-1,179
| -2% | -$106K | 0.23% | 83 |
|
|
2021
Q2 | $5.65M | Sell |
59,271
-441
| -0.7% | -$42K | 0.24% | 89 |
|
|
2021
Q1 | $6.8M | Buy |
+59,712
| New | +$6.8M | 0.31% | 86 |
|